25-year-old man has regrown scalp and facial hair after administration of a
rheumatoid arthritis drug by Yale scientists.
name of the drug is tofacitinib citrate.
man suffered from near total head and body hair loss due to a disease
condition called alopecia universalis.
universalis or alopecia areata universalis is a medical condition that causes
rapid loss of hair all over the body, including eyebrows and eyelashes. It occurs in 1 out of 200,000 people.
is an autoimmune disorder that can affect a person at any age.
The man underwent the trial for eight months
during which period he took a drug dosage of 10mg per day for two months,
followed by 15mg per day for the next three months.
By the end of the trial, the man had almost
completely regrown hair on his scalp, face, including eyebrows and eyelashes,
armpit and other areas of the body that he had not had for 7 years.
He did not report any adverse side effects
from the medication as per the scientists.
Currently, there is no standard long-term treatment for alopecia
The success is a milestone achieved in the treatment of this rare
'There are no good
options for long-term treatment of alopecia universalis,' said King, M.D.,
assistant professor of dermatology at Yale University School of Medicine. 'The best available science suggested this might work, and it
According to Science
citrate had been successfully used to
treat psoriasis in people and alopecia in mice.
King added the drug functions
by turning off the immune attack on hair follicles.
researchers, the drug works in some instances of psoriasis but not all.
The study featured
in the Journal of Investigative Dermatology.